))
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
1
Raising Awareness About Safe Practices and Opportunities for IV Therapy with Felicia Janovich American IV Association TRANSCRIPT
Felicia Janovich is a founding member of the American IV Association, which advocates for safe and effective IV therapies, including hydration, vitamin infusions, and treatments to support patients with chronic conditions or undergoing chemotherapy. While there is limited research on the effectiveness of these IV therapies, AIVA is working to colle…
…
continue reading
1
Raising Awareness About Safe Practices and Opportunities for IV Therapy with Felicia Janovich American IV Association
20:29
Felicia Janovich is a founding member of the American IV Association, which advocates for safe and effective IV therapies, including hydration, vitamin infusions, and treatments to support patients with chronic conditions or undergoing chemotherapy. While there is limited research on the effectiveness of these IV therapies, AIVA is working to colle…
…
continue reading
1
Tolerable Oral Alzheimer’s Medication to Manage Symptoms Slow Progression with Michael McFadden Alpha Cognition TRANSCRIPT
Michael McFadden is the CEO of Alpha Cognition, a biopharmaceutical company focused on developing treatments for brain diseases such as Alzheimer's, ALS, and traumatic brain injury. Their drug ZUNVEYL, recently approved by the FDA, is an oral treatment for mild to moderate Alzheimer's that improves symptoms such as memory loss, mental processing sp…
…
continue reading
1
Tolerable Oral Alzheimer’s Medication to Manage Symptoms Slow Progression with Michael McFadden Alpha Cognition
19:02
Michael McFadden is the CEO of Alpha Cognition, a biopharmaceutical company focused on developing treatments for brain diseases such as Alzheimer's, ALS, and traumatic brain injury. Their drug ZUNVEYL, recently approved by the FDA, is an oral treatment for mild to moderate Alzheimer's that improves symptoms such as memory loss, mental processing sp…
…
continue reading
1
Robust Cybersecurity Risk Management in the Healthcare Ecosystem with George Pappas Intraprise Health TRANSCRIPT
George Pappas, CEO of Intraprise Health, works with various healthcare organizations across the healthcare industry and healthcare ecosystem to help address cybersecurity risks. While recent cyber attacks have raised awareness about the need for better cybersecurity measures, the complexity of healthcare IT systems creates significant challenges fo…
…
continue reading
1
Robust Cybersecurity Risk Management in the Healthcare Ecosystem with George Pappas Intraprise Health
18:27
George Pappas, CEO of Intraprise Health, works with various healthcare organizations across the healthcare industry and healthcare ecosystem to help address cybersecurity risks. While recent cyber attacks have raised awareness about the need for better cybersecurity measures, the complexity of healthcare IT systems creates significant challenges fo…
…
continue reading
1
Developing Non-Opioid Pain Medication with Reduced Abuse Potential with Ketan Mehta Tris Pharma TRANSCRIPT
Ketan Mehta, Founder and CEO of Tris Pharma, is focused on developing non-addictive pain medication. Their lead drug candidate is designed to be an effective pain drug without the respiratory-depressive and addictive side effects of traditional opioid drugs. This drug works by targeting the nociceptin receptor and has also shown promise to help cur…
…
continue reading
1
Developing Non-Opioid Pain Medication with Reduced Abuse Potential with Ketan Mehta Tris Pharma
18:53
Ketan Mehta, Founder and CEO of Tris Pharma, is focused on developing non-addictive pain medication. Their lead drug candidate is designed to be an effective pain drug without the respiratory-depressive and addictive side effects of traditional opioid drugs. This drug works by targeting the nociceptin receptor and has also shown promise to help cur…
…
continue reading
Beth Houck, Chief Executive Officer at SonarMD, works with payers and physician practices to provide proactive, value-based care for patients with chronic GI conditions. They use a digital platform to monitor self-reported patient symptoms and enable physicians to identify those patients that need attention. This approach aims to improve patient ou…
…
continue reading
Beth Houck, Chief Executive Officer at SonarMD, works with payers and physician practices to provide proactive, value-based care for patients with chronic GI conditions. They use a digital platform to monitor self-reported patient symptoms and enable physicians to identify those patients that need attention. This approach aims to improve patient ou…
…
continue reading
1
How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton Certara TRANSCRIPT
Dr. Chris Bouton, the Senior VP and Head of Artificial Intelligence at Certara, is exploring applying generative AI to drug discovery and development to improve efficiency and identify novel therapeutics across various use cases. The focus is on developing specialized secure AI models to integrate internal data with the Certara platform. Generative…
…
continue reading
1
How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton Certara
19:27
Dr. Chris Bouton, the Senior VP and Head of Artificial Intelligence at Certara, is exploring applying generative AI to drug discovery and development to improve efficiency and identify novel therapeutics across various use cases. The focus is on developing specialized secure AI models to integrate internal data with the Certara platform. Generative…
…
continue reading
1
Unique Fat-Inhibiting Approach Targets Multiple Pathways in Metabolic Liver Disease with David Happel Sagimet Biosciences TRANSCRIPT
David Happel is President and CEO of Sagimet Biosciences, a company developing drugs to treat metabolic diseases by targeting the underlying cause of fat accumulation in the liver. The drug denifanstat limits the activity of fatty acid synthase (FASN), an enzyme that regulates fat accumulation. This approach is a fat inhibitor, not a fat burner, th…
…
continue reading
1
Unique Fat-Inhibiting Approach Targets Multiple Pathways in Metabolic Liver Disease with David Happel Sagimet Biosciences
24:15
David Happel is President and CEO of Sagimet Biosciences, a company developing drugs to treat metabolic diseases by targeting the underlying cause of fat accumulation in the liver. The drug denifanstat limits the activity of fatty acid synthase (FASN), an enzyme that regulates fat accumulation. This approach is a fat inhibitor, not a fat burner, th…
…
continue reading
1
Untangling the Complexity of the 340B Drug Discount and Medicaid Drug Rebate Programs with Dr. Gavin Magaha Kalderos TRANSCRIPT
Dr. Gavin Magaha, Senior Director for External Affairs and Policy at Kalderos, describes the 340B drug discount program created in 1992 to help safety net healthcare providers obtain discounted drugs. Over time, this program has grown in complexity, and issues have arisen around duplicate discounts where Medicaid rebates are involved. The current 3…
…
continue reading
1
Untangling the Complexity of the 340B Drug Discount and Medicaid Drug Rebate Programs with Dr. Gavin Magaha Kalderos
19:05
Dr. Gavin Magaha, Senior Director for External Affairs and Policy at Kalderos, describes the 340B drug discount program created in 1992 to help safety net healthcare providers obtain discounted drugs. Over time, this program has grown in complexity, and issues have arisen around duplicate discounts where Medicaid rebates are involved. The current 3…
…
continue reading
1
Using AI Big Data to Engineer More Efficient Drugs to Treat Rare and Common Diseases with Chris Hart Creyon Bio TRANSCRIPT
Chris Hart, Co-Founder, CEO, and President of Creyon Bio, is focused on engineering drugs rather than just discovering them through serendipity and traditional methods. Creyon is developing oligonucleotide medicines for rare and common diseases by applying AI and big data models of the molecular and genetic basis of diseases to develop safe and eff…
…
continue reading
1
Using AI Big Data to Engineer More Efficient Drugs to Treat Rare and Common Diseases with Chris Hart Creyon Bio
20:51
Chris Hart, Co-Founder, CEO, and President of Creyon Bio, is focused on engineering drugs rather than just discovering them through serendipity and traditional methods. Creyon is developing oligonucleotide medicines for rare and common diseases by applying AI and big data models of the molecular and genetic basis of diseases to develop safe and eff…
…
continue reading
1
Palatable Elemental Diet Changes Management Options for GI Patients with Krystyna Houser mBIOTA Labs TRANSCRIPT
Krystyna Houser is the Founder of mBIOTA Labs, a company that develops effective and tolerable elemental diets and medical foods for treating gastrointestinal disorders such as IBS, IBD, SIBO, IMO, and Crohn's disease. While short-term liquid elemental diets have been used in the past to treat GI conditions, the formulation has been very unpalatabl…
…
continue reading
1
Palatable Elemental Diet Changes Management Options for GI Patients with Krystyna Houser mBIOTA Labs
15:23
Krystyna Houser is the Founder of mBIOTA Labs, a company that develops effective and tolerable elemental diets and medical foods for treating gastrointestinal disorders such as IBS, IBD, SIBO, IMO, and Crohn's disease. While short-term liquid elemental diets have been used in the past to treat GI conditions, the formulation has been very unpalatabl…
…
continue reading
1
Developing Combination Therapies Targeting Hallmarks of Aging to Address Multiple Age-Related Diseases with Dr. Ann Beliën Rejuvenate TRANSCRIPT
Dr. Ann Beliën, Chief Executive Officer and Founder at Rejuvenate Biomed, is addressing the underlying biology of aging including mechanisms like mitochondrial health, cell-cell communication and inflammation in order to promote healthy aging. Taking a combination therapy approach, Rejuvenate is using AI-enable drug discovery to address multiple pa…
…
continue reading
1
Developing Combination Therapies Targeting Hallmarks of Aging to Address Multiple Age-Related Diseases with Dr. Ann Beliën Rejuvenate
19:15
Dr. Ann Beliën, Chief Executive Officer and Founder at Rejuvenate Biomed, is addressing the underlying biology of aging including mechanisms like mitochondrial health, cell-cell communication and inflammation in order to promote healthy aging. Taking a combination therapy approach, Rejuvenate is using AI-enable drug discovery to address multiple pa…
…
continue reading
1
Reimagining Blood Testing with Micro-Sampling and More Access for Collection with Eric Olson BetterWay by Babson Diagnostics TRANSCRIPT
Eric Olson, COO and Founder of BetterWay™ by Babson Diagnostics™, reports that traditional blood testing is often seen as inconvenient and unpleasant, causing 40% of people to avoid needed blood tests. Babson has developed a more patient-friendly approach to blood collection using a device that fits on the finger and requires a minimum amount of bl…
…
continue reading
1
Reimagining Blood Testing with Micro-Sampling and More Access for Collection with Eric Olson BetterWay by Babson Diagnostics
21:19
Eric Olson, COO and Founder of BetterWay™ by Babson Diagnostics™, reports that traditional blood testing is often seen as inconvenient and unpleasant, causing 40% of people to avoid needed blood tests. Babson has developed a more patient-friendly approach to blood collection using a device that fits on the finger and requires a minimum amount of bl…
…
continue reading
1
Improving Women’s Health with Advanced Gynecological Tools with Marylyn Rigby Bioceptive TRANSCRIPT
Marylyn Rigby, President and CEO of Bioceptive, focuses on improving women's health technologies. Bioceptive has developed a cervical suction retractor as an alternative to the 200-year-old cervical tenaculum device used to insert IUDs and perform biopsies and other intrauterine procedures. While current procedures are extremely painful, there has …
…
continue reading
